Correlation Between Level Biotechnology and CVC Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Level Biotechnology and CVC Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Level Biotechnology and CVC Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Level Biotechnology and CVC Technologies, you can compare the effects of market volatilities on Level Biotechnology and CVC Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Level Biotechnology with a short position of CVC Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Level Biotechnology and CVC Technologies.

Diversification Opportunities for Level Biotechnology and CVC Technologies

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Level and CVC is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Level Biotechnology and CVC Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CVC Technologies and Level Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Level Biotechnology are associated (or correlated) with CVC Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CVC Technologies has no effect on the direction of Level Biotechnology i.e., Level Biotechnology and CVC Technologies go up and down completely randomly.

Pair Corralation between Level Biotechnology and CVC Technologies

Assuming the 90 days trading horizon Level Biotechnology is expected to under-perform the CVC Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Level Biotechnology is 7.0 times less risky than CVC Technologies. The stock trades about -0.14 of its potential returns per unit of risk. The CVC Technologies is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  2,045  in CVC Technologies on October 11, 2024 and sell it today you would earn a total of  290.00  from holding CVC Technologies or generate 14.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Level Biotechnology  vs.  CVC Technologies

 Performance 
       Timeline  
Level Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Level Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Level Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
CVC Technologies 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in CVC Technologies are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, CVC Technologies may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Level Biotechnology and CVC Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Level Biotechnology and CVC Technologies

The main advantage of trading using opposite Level Biotechnology and CVC Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Level Biotechnology position performs unexpectedly, CVC Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVC Technologies will offset losses from the drop in CVC Technologies' long position.
The idea behind Level Biotechnology and CVC Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets